跳到正文
ECA GMP News·AI 评分41

ECA“GDP Update 2026”网络研讨会问答第四部分:兽药分销与CSV/AI应用

Questions and Answers from the ECA Webinar "GDP Update 2026" - Part 4

AI 导读

ECA于2026年3月12日举办的“GDP Update 2026”网络研讨会约有120名参会者,第四部分问答由演讲者Christian Grote-Westrick博士书面作答,内容涉及兽药分销商WDA与GDP证书要求,以及Microsoft SharePoint文件管控验证、AI提示词验证和监管检查对AI生成文件的反馈。

正文 · 原文

Around 120 participants attended the ECA Webinar “GDP Update 2026” on 12 March 2026. The aim of this two-and-a-half-hour session was to provide participants with a comprehensive overview of current developments and key updates in the field of Good Distribution Practice (GDP).The webinar was divided into a regulatory and an operational part. The following topics were addressed: ZLG (Germany) – GDP for active substances in Germany MHRA (UK) – Requirements for sea and air transport Swissmedic (Switzerland) – When to report changes to authorities?; Guideline on the return of medicinal products; Requirements for supply chain traceability HPRA (Ireland) – Update GDP Guidance FDA/USP (USA) – Implementation of DSCSA; Temperature mapping & transport validation; Use of Mean Kinetic Temperature EMA/ECA – GDPA: Practical implementation of GDP; When is a wholesale license necessary? GDP Non-compliance reports – GDP deviations and observations 2025; Potential preventive measures Vehicle qualification – Best practice from ECA training Storage at -40 °C – GDP for biopharmaceutical API Excursus – AI applications in the GDP environmentDuring the final Q&A session, numerous interesting aspects were raised and discussed. Following the webinar, the speaker, Dr Christian Grote-Westrick, provided written answers to all submitted questions.Below you will find Part 4 of the questions and answers. All responses reflect the speaker’s personal views based on his professional experience. Part 1 (returns/Swissmedic, USA, HPRA), Part 2 (temperature control) and Part 3 (transport validation and Annex 15) can be found in our news archive. The fifth and final part will be published next month.Veterinary Medicinal Products1. In some countries, not all distributors of veterinary medicinal products have WDAs yet, let alone GDP certificates, mainly due to regulatory backlogs. What are the expectations in this regard?Answer: As soon as wholesaling is performed by companies handling veterinary pharmaceuticals a WDA is obligatory. If this company represents a logistics service provider (product still belongs to you) a "commercial" GDP certificate (not issued by competent authority but by commercial organization) of the company may be available. This could be a parameter in your supplier qualification, but this is not an official GDP certificate (also not required, because no wholesaling is performed). Computer System Validation (CSV) / Artificial Intelligence (AI)1. How should validation of Microsoft SharePoint for the storage of GDP documentation be approached?Answer: Short answer: if MS SharePoint is validated according to ALCOA++, it is suitable for document control. SharePoint offers versioning of documents and comments by authorized users with time stamps, which can be applied for document authorship / review / release evidences. A validation approach which covers ALCOA++, especially availability, durability and protection for electronic data would be recommended. 2. Regarding validated prompts, how was the validation process conducted?Answer: So far, an approach: training of the AI until the process is clear in its execution can be seen as design qualification, because their own requirements (user requirement specification) is matched with AI abilities. Often no influence can be made on installation and operation, thus, especially properties such as reproducibility, repeatability and correctness should be the target in PQ. Here, a static AI represents a prerequisite. 3. Have you received any feedback during regulatory inspections regarding documents created using AI (e.g. Management Review, Periodic Review), and what are regulators’ expectations?Answer: As soon as AI activities are subject of human review and release and prompts contain an individual validation, those supportive tasks have been seen as beneficial for first-time-right documentation.

来源:ECA GMP News · gmp-compliance.org